Multi-gene Subunit Vaccine Platform Against Y. pestis
Multi-gene Subunit Vaccine Platform Against Y. pestis
批准号:
8129744
负责人:
Shan Lu
金额:
$41.12万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2013-08-31
关键词:
AdjuvantAnimal ModelAnimalsAntibody FormationAntigensApplications GrantsAreaBacteriaBioterrorismCategoriesCellular ImmunityClinicalClinical ResearchClinical TrialsCryopreservationDNADNA VaccinesDNA deliveryDataDevelopmentDevicesDoseDrug FormulationsEffectivenessElectroporationEmerging Communicable DiseasesEngineeringEvaluationExpression LibraryFundingFutureGenesGoalsGrantHumanImmuneImmune responseImmune systemImmunizationIndividualInfectionInjection of therapeutic agentInstitutesKnowledgeLanguageLongevityMaintenanceMassachusettsMediatingMemory B-LymphocyteMethodologyModelingNeedlesNew EnglandPathogenesisPhasePlaguePlague VaccinePopulationPositioning AttributePreparationProtein MicrochipsProteinsProteomicsPublishingRecombinant ProteinsRecombinant VaccinesResearchResearch PersonnelResistanceRoleRouteScreening procedureSeriesSerumSourceSpecific qualifier valueSubunit VaccinesSystemTechniquesTechnologyTestingTranslatingUnited States National Institutes of HealthUniversitiesVaccine DesignVaccinesValidationWorkYersinia pestisbasebiodefensecell mediated immune responsedesignefficacy evaluationflexibilityhigh throughput screeninghuman studyimmunogenicityimprovedinstrumentinterestmedical schoolsmeetingsnonhuman primatenovelparticlepathogenpre-clinicalproduct developmentprogramsprotective efficacyprotein expressionresearch clinical testingresponsetoolvaccine candidatevaccine deliveryvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this application is to develop improved plague vaccines. Our proposal was developed based on our recent progress in plague vaccine studies which includes 1.) the use of a DNA immunization approach to search for additional protective antigens and 2.) the discovery of cell mediated immune responses in the protection of Y. pestis infection. Support for the current proposal will allow us to develop a unique technological platform which can combine antigen discovery, optimization of vaccine formulation, and efficient needle free intradermal delivery of subunit-based multi-gene plague vaccines into one system.
Specific Aim 1: To continue our work using DNA immunization as a tool to screen for additional protective antigens against plague, including both the study of individual candidate antigens and the high throughput screening of animal sera which has been immunized with specialized Y. pestis strains deficient for the dominant antigens LcrV and F1. This approach exploits the availability of a newly constructed Y. pestis expression library and protein microarray techniques.
Specific Aim 2: To study the cellular immunological mechanisms that are important for improving the protective efficacy of plague vaccines which includes the use of the DNA prime plus protein boost approach to increase the level and longevity of protective antibody responses induced by subunit plague vaccines.
Specific Aim 3: To conduct late-phase preclinical immunogenicity and protection studies in non-human primates to prepare for a clinical study with optimized plague vaccine formulation and DNA delivery device that has been proven effective in humans.
Plain, lay language summary: This study is designed to produce effective biodefense vaccines against Y. pestis, the highly lethal bacteria that causes plague, an infection that has the potential to cause a high percentage of human fatalities. This study is part of the broad biodefense effort to protect against such agents if they were to be used for bioterrorism purposes.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
LcrV DNA 疫苗中 CD8 T 细胞介导的免疫反应的参与诱导了针对致命性鼠疫耶尔森氏菌攻击的保护。
DOI:
10.1016/j.vaccine.2010.12.062
发表时间:
2011
期刊:
Vaccine
影响因子:
5.5
作者:
[Wang,Shixia, Goguen,JonD, Li,Fusheng, Lu,Shan]
通讯作者:
Lu,Shan
DOI:
10.1371/journal.pone.0091679
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Li J, Han Y, Xing Y, Li S, Kong L, Zhang Y, Zhang L, Liu N, Wang Q, Wang S, Lu S, Huang Z]
通讯作者:
Huang Z
DOI:
10.1371/journal.pone.0021942
发表时间:
2011
期刊:
PloS one
影响因子:
3.7
作者:
[Suguitan AL Jr, Cheng X, Wang W, Wang S, Jin H, Lu S]
通讯作者:
Lu S
DOI:
10.1371/journal.pone.0101788
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Huang R, Zhang L, Gu Q, Zhou YH, Hao Y, Zhang K, Liu Y, Dong D, Wang S, Huang Z, Lu S, Wu C]
通讯作者:
Wu C
Technical transformation of biodefense vaccines.
生物防御疫苗技术改造。
DOI:
10.1016/j.vaccine.2009.08.055
发表时间:
2009
期刊:
Vaccine
影响因子:
5.5
作者:
[Lu,Shan, Wang,Shixia]
通讯作者:
Wang,Shixia
共 9 条
Optimizing the immunogenicity of next generation polyvalent HIV vaccine formulati
-
批准号:8499206
-
项目类别:
-
资助金额:$234.3万
-
财政年份:2013
-
负责人:Shan Lu
-
依托单位:
Optimization of HIV vaccines for the induction of cross-reactive antibodies
-
批准号:7883581
-
项目类别:
-
资助金额:$236.62万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Optimization of HIV vaccines for the induction of cross-reactive antibodies
-
批准号:8303374
-
项目类别:
-
资助金额:$137.29万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Optimization of HIV vaccines for the induction of cross-reactive antibodies
-
批准号:8499205
-
项目类别:
-
资助金额:$294.72万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Optimizing the immunogenicity of next generation polyvalent HIV vaccine formulati
-
批准号:7701147
-
项目类别:
-
资助金额:$46.62万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Optimization of HIV vaccines for the induction of cross-reactive antibodies
-
批准号:7665598
-
项目类别:
-
资助金额:$231.33万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Administrative Core
-
批准号:7664150
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
-
批准号:8118542
-
项目类别:
-
资助金额:$197.58万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Administrative Core
-
批准号:7701150
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
-
批准号:8513885
-
项目类别:
-
资助金额:$202.66万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
-
批准号:7645923
-
项目类别:
-
资助金额:$185.76万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
CD4bs antigenicity, neutralization and immunogenicity of primary HIV-1 Env
-
批准号:7664143
-
项目类别:
-
资助金额:$39.76万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
-
批准号:8310009
-
项目类别:
-
资助金额:$200.73万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
-
批准号:7907754
-
项目类别:
-
资助金额:$185.26万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Optimization of HIV vaccines for the induction of cross-reactive antibodies
-
批准号:8103325
-
项目类别:
-
资助金额:$605.04万
-
财政年份:2009
-
负责人:Shan Lu
-
依托单位:
Multi-gene Subunit Vaccine Platform Against Y. pestis
-
批准号:7684195
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2008
-
负责人:Shan Lu
-
依托单位:
Multi-gene Subunit Vaccine Platform Against Y. pestis
-
批准号:7455420
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2008
-
负责人:Shan Lu
-
依托单位:
Multi-gene Subunit Vaccine Platform Against Y. pestis
-
批准号:7916646
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2008
-
负责人:Shan Lu
-
依托单位:
Polyvalent DNA Plus Protein HIV Vaccines
-
批准号:7167910
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2006
-
负责人:Shan Lu
-
依托单位:
Polyvalent DNA Plus Protein HIV Vaccines
-
批准号:7261244
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2006
-
负责人:Shan Lu
-
依托单位:
海外基金